{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:44:21Z","timestamp":1792165461669,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.urology.2025.07.055","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T15:04:35Z","timestamp":1753974275000},"page":"56-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Prostate Specific Antigen Testing and Prostate Cancer Diagnosis Rates Among Transgender and Non-Binary Patients: Retrospective Review of a Single-Institution Experience"],"prefix":"10.1016","volume":"206","author":[{"given":"Jamie A.","family":"Michael","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Ascha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Gonzales-Alabastro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Chwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Felt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Beach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumanas W.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana K.","family":"Bowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2025.07.055_bib1","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.2105\/AJPH.2012.300796","article-title":"Experiences of transgender-related discrimination and implications for health: results from the Virginia Transgender Health Initiative Study","volume":"103","author":"Bradford","year":"2013","journal-title":"Am J Public Health"},{"key":"10.1016\/j.urology.2025.07.055_bib2","unstructured":"Grant JM, Mottet LA, Tanis J. Injustice at every turn: a report of the national transgender discrimination survey. National Center for Transgender Equality and National Gay and Lesbian Task Force: Washington, DC; 2011."},{"key":"10.1016\/j.urology.2025.07.055_bib3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1472-6963-12-110","article-title":"Completely out-at-sea\u201d with \u201ctwo-gender medicine\u201d: a qualitative analysis of physician-side barriers to providing healthcare for transgender patients","volume":"12","author":"Snelgrove","year":"2012","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.urology.2025.07.055_bib4","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1503\/cmaj.109-4839","article-title":"Screening programs overlook transgender people","volume":"186","author":"Vogel","year":"2014","journal-title":"CMAJ"},{"key":"10.1016\/j.urology.2025.07.055_bib5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1089\/trgh.2019.0083","article-title":"Provider recommendations are associated with cancer screening of transgender and gender-nonconforming people: a cross-sectional urban survey","volume":"5","author":"Pratt-Chapman","year":"2020","journal-title":"Transgend Health"},{"key":"10.1016\/j.urology.2025.07.055_bib6","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2018.3710","article-title":"Screening for prostate cancer: US preventive services task force recommendation statement","volume":"319","author":"Grossman","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2025.07.055_bib7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.6004\/jnccn.2023.0014","article-title":"NCCN Guidelines\u00ae insights: prostate cancer early detection, version 1.2023: Featured updates to the NCCN Guidelines","volume":"21","author":"Moses","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.urology.2025.07.055_bib8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.juro.2013.04.119","article-title":"Early detection of prostate cancer: AUA guideline","volume":"190","author":"Carter","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2025.07.055_bib9","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/JU.0000000000001430","article-title":"Use of the MyProstateScore test to rule out clinically significant cancer: validation of a straightforward clinical testing approach","volume":"205","author":"Tosoian","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2025.07.055_bib10","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.juro.2009.12.056","article-title":"[-2]Proenzyme prostate specific antigen is more accurate than total and free prostate specific antigen in differentiating prostate cancer from benign disease in a prospective prostate cancer screening study","volume":"183","author":"Le","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2025.07.055_bib11","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/S1470-2045(15)00361-7","article-title":"Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study","volume":"16","author":"Gr\u00f6nberg","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.urology.2025.07.055_bib12","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/and.12208","article-title":"Prostate cancer incidence in orchidectomised male-to-female transsexual persons treated with oestrogens","volume":"46","author":"Gooren","year":"2014","journal-title":"Andrologia"},{"key":"10.1016\/j.urology.2025.07.055_bib13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.urology.2017.08.032","article-title":"Prostate cancer in transgender women: incidence, etiopathogenesis, and management challenges","volume":"110","author":"Deebel","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.urology.2025.07.055_bib14","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1080\/15532739.2011.700873","article-title":"Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7","volume":"13","author":"Coleman","year":"2012","journal-title":"Int J Transgend"},{"key":"10.1016\/j.urology.2025.07.055_bib15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/aogs.12618","article-title":"Sex reassignment of transsexual people from a gynecologist\u2019s and urologist\u2019s perspective","volume":"94","author":"Trum","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.urology.2025.07.055_bib16","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.urolonc.2018.09.011","article-title":"Prostate cancer in transgender women","volume":"36","author":"Ingham","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urology.2025.07.055_bib17","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/jnci\/djab028","article-title":"Cancer stage, treatment, and survival among transgender patients in the United States","volume":"113","author":"Jackson","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urology.2025.07.055_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/bju.15521","article-title":"Prostate cancer in transgender women: What does a urologist need to know?","volume":"129","author":"Bertoncelli Tanaka","year":"2022","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2025.07.055_bib19","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/pros.23322","article-title":"The development of prostate adenocarcinoma in a transgender male to female patient: Could estrogen therapy have played a role?","volume":"77","author":"Sharif","year":"2017","journal-title":"Prostate"},{"key":"10.1016\/j.urology.2025.07.055_bib20","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/ gender-incongruent persons: an Endocrine Society\u2217clinical practice guideline","volume":"102","author":"Hembree","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.urology.2025.07.055_bib21","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1001\/jamaoncol.2022.4319","article-title":"Association of prostate-specific antigen screening rates with subsequent metastatic prostate cancer incidence at US veterans health administration facilities","volume":"8","author":"Bryant","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.urology.2025.07.055_bib22","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.eururo.2020.11.009","article-title":"Prostate cancer screening patterns among sexual and gender minority individuals[Formula presented]","volume":"79","author":"Ma","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2025.07.055_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.urology.2023.03.016","article-title":"Disparities in prostate cancer screening for transgender women: an analysis of the MarketScan Database","volume":"176","author":"Premo","year":"2023","journal-title":"Urology"},{"key":"10.1016\/j.urology.2025.07.055_bib24","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/pros.24355","article-title":"Prostate cancer awareness among transgender women after gender-affirming surgery","volume":"82","author":"Pitak-Arnnop","year":"2022","journal-title":"Prostate"},{"key":"10.1016\/j.urology.2025.07.055_bib25","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.21037\/tau-20-1052","article-title":"Every urologist and oncologist should know about treating sexual and gender minority prostate cancer patients: translating research findings into clinical practice","volume":"10","author":"Rosser","year":"2021","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.urology.2025.07.055_bib26","first-page":"35","article-title":"Gynaecological aspects of the treatment and follow-up of transsexual men and women","volume":"2","author":"Weyers","year":"2010","journal-title":"Facts Views Vis ObGyn"},{"key":"10.1016\/j.urology.2025.07.055_bib27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jama.2024.9997","article-title":"Prostate-Specific Antigen values in transgender women receiving estrogen","volume":"332","author":"Nik-Ahd","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2025.07.055_bib28","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1001\/jama.2023.6028","article-title":"Prostate cancer in transgender women in the veterans affairs health system, 2000-2022","volume":"329","author":"Nik-Ahd","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2025.07.055_bib29","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s11930-019-00234-7","article-title":"Understanding prostate cancer in gay, bisexual, and other men who have sex with men and transgender women: a review of the literature","volume":"11","author":"Rosser","year":"2019","journal-title":"Curr Sex Health Rep"},{"key":"10.1016\/j.urology.2025.07.055_bib30","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/jamaoncol.2019.0826","article-title":"Association of black race with prostate cancer-specific and other-cause mortality","volume":"5","author":"Dess","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.urology.2025.07.055_bib31","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/onco.13749","article-title":"Prostate cancer: community education and disparities in diagnosis and treatment","volume":"26","author":"Carthon","year":"2021","journal-title":"Oncologist"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429525007356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429525007356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T14:05:22Z","timestamp":1765289122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429525007356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":31,"alternative-id":["S0090429525007356"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2025.07.055","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostate Specific Antigen Testing and Prostate Cancer Diagnosis Rates Among Transgender and Non-Binary Patients: Retrospective Review of a Single-Institution Experience","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2025.07.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}